Masterclass: Design and Control Conditions for Clinical Trials of Digital Health Solutions

Clinical efficacy is a crucial factor for the commercial success of Digital Health solutions. In order to demonstrate their value to stakeholders such as payers, healthcare professionals, investors, and others, it's essential to have a well-designed clinical trial that accurately captures the impact of the DTx solution.

Join this masterclass led by David Hohenschurz-Schmidt (researcher, therapist and DTx consultant, Imperial College London), where we will dive into the process of designing clinical trials for Digital Health solutions and how to select the right control conditions for every digital health solution: 

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.